New AccuCode CV Platform Brings Specialty-Specific Intelligence to Cardiovascular Coding

The AI-augmented cardiovascular coding engine improves accuracy, decreases turnaround times and reduces costs

JACKSONVILLE BEACH, Fla.--(BUSINESS WIRE)--MedAxiom and AccuCode AI today announced the launch of AccuCode CV, an artificial intelligence (AI)-augmented cardiovascular coding engine that optimizes revenue integrity by improving accuracy, decreasing turnaround times and reducing costs.

This first-of-its-kind platform applies specialty-specific intelligence to the most complex and highest-risk cardiovascular coding scenarios, helping provider organizations improve coding accuracy, efficiency, quality and confidence—supporting revenue integrity while fitting into existing revenue cycle workflows.

Key benefits include:

• Improves accuracy: Increases consistency and reliability with cardiovascular-specific coding logic, continuously updated guidelines and built-in validation rules.
• Decreases turnaround times: Accelerates throughput and shortens submission cycles by automating time-consuming steps—shrinking backlogs and enabling faster, cleaner claim submission.
• Reduces costs: Minimizes rework and denial-related expenses while optimizing staff to work at the top of their skillsets—maximizing existing resources without added disruption.

AccuCode CV is delivered through a strategic partnership between MedAxiom and AccuCode AI, combining MedAxiom’s deep cardiovascular expertise with AccuCode AI’s pioneering technology.

“In cardiovascular care—one of the most complex and high-stakes areas of healthcare—coding precision is critical, and even small gaps can translate into meaningful revenue loss,” said Jerry Blackwell, MD, MBA, FACC, president and CEO of MedAxiom. “AccuCode CV uses AI-driven, cardiovascular-specific logic to augment coders, not replace them, with a human-in-the-loop process that keeps revenue cycle teams in control.”

“AccuCode CV applies AI through a proprietary, multi-step process that ingests documentation, interprets clinical context and validates code relationships against continuously updated guidelines,” said Nathan R. Myers, president and CEO of AccuCode AI. “That approach helps teams deliver more consistent cardiovascular coding—faster—while keeping coders at the center.”

To learn more and request a demo, visit AccuCodeCV.com.

About AccuCode CV
AccuCode CV is an AI-augmented cardiovascular coding engine delivered through a strategic partnership between MedAxiom and AccuCode AI, combining MedAxiom’s deep cardiovascular expertise with AccuCode AI’s pioneering technology. The platform is designed for cardiovascular practices, hospital cardiovascular service lines, and revenue cycle teams to help improve coding accuracy, efficiency, quality and confidence while supporting revenue integrity.

About MedAxiom
MedAxiom, an American College of Cardiology Company, is the cardiovascular community’s premier source for organizational performance solutions. MedAxiom is transforming cardiovascular care by combining the knowledge and power of hundreds of cardiovascular organization members, thousands of administrators, clinicians and revenue cycle experts, and dozens of industry partners. Through the delivery of proprietary tools, smart data and proven strategies, MedAxiom helps cardiovascular organizations achieve the Quadruple Aim of better outcomes, lower costs, improved patient experience and improved clinician experience.

About AccuCode AI
Founded in 2023, AccuCode AI is at the forefront of healthcare transformation through advanced artificial intelligence algorithms. The company provides automation solutions for clinical quality measures, document processing and data abstraction, serving clinics, hospitals and healthcare organizations nationwide with a commitment to accuracy, security and innovation.